The management of locally advanced lung cancer increasingly relies on multidisciplinary collaboration. Advances in neoadjuvant and perioperative chemoimmunotherapy have significantly improved outcomes for patients with resectable non-small cell lung cancer.
This combined immunotherapy track and lung cancer track brings together leading experts to discuss recent, cutting-edge trials and strategies in treating both locally advanced and metastatic non-small cell lung cancer (NSCLC). Dr.
This activity discusses some of the newer treatment techniques, including stereotactic body radiation (SBRT), adaptive radiation therapy and protons being utilized in gynecologic cancer.
The Michigan Radiation Oncology Quality Consortium (MROQC) is a Blue Cross Blue Shield of Michigan-Blue Care Network (BCBSM-BCN) sponsored Collaborative Quality Initiative (CQI).
Molecular testing is an integral component of multidisciplinary management of breast cancer. Recent evidence underscores the importance of molecular assays in radiation therapy decision making.
There is a significant gap in the knowledge and practice of integrating novel systemic therapies with radiotherapy in breast cancer management, particularly due to limited clinical trial data on their combined use.
Brachytherapy is an invaluable tool in the radiation oncologist's toolbox, but the perceived proficiency among residents has been variable and there is great diversity in how programs deliver brachytherapy.
This educational series explores the evolving role of radiation therapy in managing nonmalignant conditions, addressing current challenges, emerging evidence, and specialized applications in clinical practice.
This activity is a case-based discussion on the role of radiation therapy in the treatment of cutaneous squamous cell carcinoma. We have three academic physicians representing three different geographic locations within the United States, from the east coast, west coast and sun belt region.
This activity is a case-based discussion on the role of radiation therapy in the treatment of cutaneous squamous cell carcinoma. We have three academic physicians representing three different geographic locations within the United States, from the east coast, west coast and sun belt region.
Facebook
X
LinkedIn
Forward
